First of all I would like to congratulate everyone associated with our FDA approved neurodevelopment disorder drug Trofinetide.
I can only imagine what this means to all sufferers and their families, especially Mellan and Katelin.
Jon Pilcher and his associates must be high fiving all around and getting down to drafting the announcement for Monday pre-open; I’m not going to try to guess what the SP may end at on Monday because it may depend on how the announcement is worded; hopefully it may just include a breadcrumb relating to ROW, if it does we may get a pleasant surprise, also the ASX may want a little guidance from the ACAD SP on Monday night.
GLTAH.
FDA Approved, page-15
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.14 |
Change
-0.130(0.85%) |
Mkt cap ! $1.935B | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.47 | $14.93 | $7.335M | 485.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7079 | $15.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.17 | 3189 | 3 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |